Keigo Saito

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.

Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.

Journal: Cancer science

Published: April 06, 2022

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer.

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer.

Journal: Cancer science

Published: February 14, 2020

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Journal: Cancer science

Published: November 28, 2019

Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma.

Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma.

Journal: Cancer science

Published: July 28, 2019

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.

Journal: Oncology letters

Published: June 14, 2019

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma.

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma.

Journal: Oncoimmunology

Published: April 18, 2017

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

Journal: Oncoimmunology

Published: April 18, 2017

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.

Journal: Oncotarget

Published: March 23, 2016

Biomarkers for the early diagnosis of hepatocellular carcinoma.

Biomarkers for the early diagnosis of hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: March 17, 2015

A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer.

A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer.

Journal: International journal of oncology

Published: August 29, 2014

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: January 01, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026